Overview

Treatment of Patients With Blepharitis and Facial Rosacea

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of sub-antimicrobial dose COL-101 in the treatment of patients who have both blepharitis and facial rosacea
Phase:
Phase 2
Details
Lead Sponsor:
Galderma
Galderma R&D
Treatments:
Doxycycline